Antibodies normally fight viruses, but in the case of flaviviruses, they can make infections worse. UArizona Health Sciences immunologists figured out why.

Antibodies normally fight viruses, but in the case of flaviviruses, they can make infections worse. Researchers took a closer look at antibody production to figure out why.

Payson now has a state-of-the-art, high-tech telemedicine clinic, with the opening of the University of Arizona College of Medicine – Phoenix Rural Health Clinic. The clinic will train medical students and also offer treatment for everyone regardless of medical insurance status, taking advantage of the latest technology to run tests, talk to specialists and manage the care of complex medical issues.

An unexpected finding gives researchers in the UArizona Health Sciences Comprehensive Pain and Addiction Center a novel target for non-opioid pain therapeutics.

Research shows SARS-CoV-2 promotes pain relief through the receptor neuropilin-1, which gives scientists a new target for non-opioid pain therapeutics and offers one possible explanation for the unrelenting spread of COVID-19.

White House Coronavirus Task Force Coordinator Dr. Deborah Birx tours labs to learn about Health Sciences’ antibody and antigen testing.

Joe Gerald, a researcher at the University of Arizona Mel and Enid Zuckerman College of Public Health who tracks the coronavirus in Arizona, said it is too early to detect spread from campus outbreaks in the state, but it may be that the overlap between students and locals is minimal enough to prevent that.

Dr. Lisa Grimaldi, an associate professor in the Division of Cardiovascular ICU at the University of Arizona College of Medicine Phoenix, said most children who have tested positive for COVID-19 do not have symptoms or have only a very mild disease. Grimaldi also is pediatric critical care physician at Phoenix Children’s Hospital. She said there are reports out of New York and Europe that children are being hospitalized with a new disease that appears to be tied to Coronavirus. Called multisystem inflammatory syndrome in children (MIS-C).

SARS-CoV-2, the virus that causes COVID-19, can relieve pain, according to a new study by University of Arizona Health Sciences researchers. The finding may explain why nearly half of people who get COVID-19 experience few or no symptoms, even though they are able to spread the disease, according to the study's senior author Rajesh Khanna, PhD, a professor in the College of Medicine -- Tucson's Department of Pharmacology.

Research shows SARS-CoV-2 promotes pain relief through the receptor neuropilin-1, which gives scientists a new target for non-opioid pain therapeutics and offers one possible explanation for the unrelenting spread of COVID-19.